文献速递胃肠外科围术期管理与 ERAS

超出内镜黏膜下剥离术适应症的早期胃癌微创治疗临床结局

Clinical outcomes of minimally invasive treatment for early gastric cancer in patients beyond the indications of endoscopic submucosal dissection.
PubMed 文献 · Surg Endosc · 2018-02-20

该回顾性研究纳入48例T1N0M0、肿瘤小于5 cm、疑似黏膜下浸润或活检弥漫型组织学的早期胃癌患者,分别接受腹腔镜前哨淋巴结清扫联合内镜黏膜下剥离术(ESN,21例)或联合内镜全层胃切除术(Hybrid-NOTES,27例)。ESN组和Hybrid-NOTES组的治愈性切除率分别为76.5%和90.9%,长期随访中仅1例ESN后出现肝转移。两种方法长期结局良好,可作为ESD与胃切除术之间的过渡治疗。

要点

  • ESN和Hybrid-NOTES可用于超出ESD适应症的早期胃癌,长期结局良好。
  • ESN组治愈性切除率为76.5%,Hybrid-NOTES组为90.9%。
  • 附加胃切除术的主要原因为手术并发症,其次为淋巴结转移和非治愈性切除。

核心结论

  • ESN和Hybrid-NOTES尽管存在技术局限性,但显示出良好的长期结局,可作为高淋巴结转移风险、超出ESD适应症的早期胃癌在ESD与胃切除术之间的过渡治疗。

研究设计与样本

  • 回顾性分析2009年1月至2013年3月接受ESN或Hybrid-NOTES治疗的早期胃癌患者,共纳入48例,其中ESN组21例,Hybrid-NOTES组27例。
  • 所有患者均为T1N0M0期,肿瘤小于5 cm,影像学怀疑黏膜下浸润或活检证实为弥漫型组织学。

主要发现

  • ESN组治愈性切除率为76.5%,Hybrid-NOTES组为90.9%。
  • ESN组5例追加胃切除术(1例因淋巴结转移,3例因手术并发症,1例因非治愈性切除)。
  • Hybrid-NOTES组6例追加胃切除术(1例因淋巴结转移,3例因手术并发症,2例因非治愈性切除)。
  • 长期随访37例(中位随访59.8个月),仅1例ESN后出现肝转移并接受姑息化疗。

临床怎么用

  • 对于超出ESD适应症、高淋巴结转移风险的早期胃癌,ESN和Hybrid-NOTES可作为ESD与胃切除术之间的过渡治疗选择。

局限性

  • 本研究为回顾性分析,样本量较小(共48例),长期随访仅37例,可能存在选择偏倚和随访不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic submucosal dissection (ESD) with laparoscopic sentinel lymph node dissection (ESN) and endoscopic full-thickness gastric resection with laparoscopic sentinel lymph node dissection (Hybrid-natural orifice transluminal endoscopic surgery, Hybrid-NOTES) are minimally invasive treatment options for early gastric cancer (EGC) beyond the indications of ESD. This study aimed to evaluate the short- and long-term clinical outcomes of ESN and Hybrid-NOTES. METHODS: We retrospectively analyzed patients who had undergone ESN or Hybrid-NOTES for EGC from January 2009 to March 2013. A total of 48 patients, including 21 undergoing ESN and 27 undergoing Hybrid-NOTES, were enrolled. All patients had cancer stage T1N0M0, EGC less than 5 cm in size, and suspected submucosal invasion according to imaging or biopsy-proven diffuse-type histology. RESULTS: In ESN and Hybrid-NOTES, the curative resection rates were 76.5% and 90.9% of patients, respectively. In the ESN group, 5 patients underwent an additional gastrectomy (1 for lymph node metastasis (LNM), 3 for surgical complications, and 1 for noncurative resection). In the Hybrid-NOTES group, 6 patients underwent additional gastrectomy, (1 for LNM, 3 for surgical complications, and 2 for noncurative resection). Of the 37 patients who were followed up in the long-term (a median follow-up of 59.8 months), one was found to have liver metastasis after ESN and received palliative chemotherapy. CONCLUSIONS: ESN and Hybrid-NOTES have shown favorable long-term outcomes despite their technical limitations. These methods may be utilized as a bridge between ESD and gastrectomy in cases of EGC with a high risk of LNM beyond the ESD indications.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ko WJ, Kim YM, Yoo IK, et al. Clinical outcomes of minimally invasive treatment for early gastric cancer in patients beyond the indications of endoscopic submucosal dissection. Surg Endosc. 2018. PMID: 29464402. doi:10.1007/s00464-018-6105-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。